Oppenheimer & Co’s Qiagen QGEN Stock Holding History

Oppenheimer & Co’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-6,196	Closed	-$320K	–	1553
2021 Q1	$320K	Buy	6,196 +1,279	+26%	+$70.3K	0.01%	1145
2020 Q4	$276K	Buy	4,917 +179	+4%	+$9.55K	0.01%	1116
2020 Q3	$263K	Buy	+4,738	New	+$246K	0.01%	1047

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Oppenheimer & Co's QGEN Position: Q2 2021 in Review

Oppenheimer & Co sold out of Qiagen (QGEN) in Q2 2021, closing a stake of 6,196 shares — an estimated $320K sold.

Oppenheimer & Co first reported a position in QGEN in Q3 2020 and held it in 3 quarters. The position peaked at $320K in Q1 2021. 257 funds tracked by Wall St. Rank hold QGEN as of Q2 2021.

Oppenheimer & Co reported no remaining Qiagen position as of Q2 2021 after selling out during the quarter.
Oppenheimer & Co sold 6,196 Qiagen shares in Q2 2021, an estimated $320K.
Oppenheimer & Co first reported a position in Qiagen in Q3 2020 and held it in 3 quarters.
Oppenheimer & Co's Qiagen position peaked at $320K in Q1 2021.
257 funds tracked by Wall St. Rank held Qiagen as of Q2 2021.

Based on Oppenheimer & Co's 13F filing for Q2 2021, filed 3 Aug 2021.